Tag Archives: Hemgenix
FDA Approves Hemgenix- World’s First Gene Therapy for Adults with Hemophilia B
On November 22, 2022, the U.S. FDA approved Hemgenix (Etranacogene Dezaparvovec; CSL Behring LLC.) for treating adults with Hemophilia B […]
